Fusion Antibodies Takeover Rumours (FAB)

Posted on LSE - Just confirms we are looking at a quid min for a FAB takeover Today 13:37 Https://www.fiercebiotech.com/cro/charles-river-laboratories-spends-83m-to-snap-up-distributed-bio-to-boost-antibody-work Imagine the fab optiphage client decides they want that whole technology - could be around this value maybe - that was just to get access to one platform and fab have multiple ones

I have a sense news flow is about to pick up fast, and holders will sit really tight. On the surface, not many big holdings, but any takeover could be quite a bidding war. An alternative scenario could be a big pharma placement of a strategic stake in FAB, which would be a win-win situation

It’s a multi bagger in 2025 trout. That’s if no takeover in the interim

They are probably far too tightly held to be an easy takeover target atm

At this price surely fab are sitting takeover target

cbeadle, I can't see it, too expensive and means they would take their eye off the ball, in terms of new contracts, development and expansion. This will be the thing that leads to a greater valuation and probably then a takeover offer(s)....